Top Beijing official admits efficacy of China’s Covid vaccines is low

Head of country’s disease control centre says vaccines ‘don’t have very high protection rates’

China’s top disease control official has admitted that the efficacy of the country’s domestically produced vaccines is low as it emerged the authorities are considering mixing them to try to offer greater protection against coronavirus.

The rare admission of weakness on the part of Beijing’s pandemic approach came from the director of the China Center for Disease Control and Prevention, Gao Fu, who said Chinese vaccines “don’t have very high protection rates”.

“It’s now under formal consideration whether we should use different vaccines from different technical lines for the immunisation process,” he said at a conference on Saturday in the south-western city of Chengdu.

The efficacy of a coronavirus vaccine from Sinovac, a Chinese developer, at preventing symptomatic infections has been found to be as low as 50.4% by researchers in Brazil. By comparison, the vaccine made by Pfizer has been found to be have an efficacy rate of 97%.

On Sunday Gao appeared to walk back his comments, according to Chinese state tabloid, the Global Times. Gao told the outlet that international interpretation of his comments as an admission had been a “misunderstanding”.

“The protection rates of all vaccines in the world are sometimes high, and sometimes low. How to improve their efficacy is a question that needs to be considered by scientists around the world,” Gao said.

But the earlier statement by Gao is likely to cause concern in the growing number of other countries who are relying on Chinese vaccines. Beijing has distributed hundreds of millions of doses in other countries while also trying to promote doubt about the efficacy of western vaccines.

China coronavirus cases

Turkey and Singapore are among countries that have placed orders while a rollout of Sinovac’s vaccine in Indonesia in January involved 3m doses and was aimed at medical workers and public servants. It subsequently approved Sinovac for use in elderly people.

It emerged last month that a number of people in the United Arab Emirates (UAE) were being invited to get a third shot of the Sinopharm coronavirus vaccine after antibody tests indicated they did not have a sufficient immune response following two doses of the Chinese-made vaccine.

Beijing has yet to approve any foreign vaccines for use in China, where the coronavirus emerged in late 2019.

China has administered about 161m doses since vaccinations began last year – most people will require two shots – and aims to fully inoculate 40% of its 1.4 billion population by June.

Last month, authorities in Beijing resumed issuing visa processing for foreigners from dozens of countries, but only if they have been inoculated against Covid-19 with a Chinese-made vaccine.

The move raised questions about the motivations behind the demand, given China’s vaccines are not approved in many of the countries to which it has opened travel and that it will not accept foreign vaccines made elsewhere, including those approved by the World Health Organization.

By the middle of last month, China had approved five vaccines for either general or emergency use, including three that are also being distributed to other countries either through trade or aid.

The push to supply internationally has been labelled a “vaccine diplomacy” campaign to boost China’s place as a global health contributor, with take-up mostly in Asia, Africa and South America.


Ben Quinn and agencies

The GuardianTramp

Related Content

Article image
Homegrown Covid vaccines fill gap as UN Covax scheme misses target
India, Egypt and Brazil among countries developing and making their own vaccines after Covax falls behind

Hazem Badr, Helen Mendes and Papiya Bhattacharya

13, Oct, 2021 @6:00 AM

Article image
China to only allow foreign visitors who have had Chinese-made vaccine
Move raises questions as China’s vaccines not approved in many countries to which it is opening travel

Helen Davidson in Taipei

17, Mar, 2021 @9:39 AM

Article image
China set to administer 1bn Covid vaccine doses by end of this week
Cash incentives and gifts offered to fulfil target of vaccinating 40% of population by end of month

Helen Davidson in Taipei

15, Jun, 2021 @12:36 PM

Article image
Vaccines are key to China’s zero-Covid exit but scepticism poses challenge
Backing down from existing policies remains a political problem of the first order

Helen Davidson

02, Dec, 2022 @12:28 PM

Article image
China approves Sinopharm Covid-19 vaccine for general use
Rollout to begin ‘soon’ but about a million have already received injection under emergency approvals

Helen Davidson in Taipei

31, Dec, 2020 @3:52 AM

Article image
China covid protests: authorities call for crackdown on ‘hostile forces’
Streets flooded with police as top security body blames ‘infiltration and sabotage’ for unrest

Emma Graham-Harrison and Helen Davidson in Taipei

29, Nov, 2022 @6:58 PM

Article image
WHO team says theory Covid began in Wuhan lab ‘extremely unlikely’
Theories including virus jumping from animal to human or via frozen food being explored by team in China

Helen Davidson in Taipei

09, Feb, 2021 @2:28 PM

Article image
Beijing colour-codes buildings to show workers’ Covid vaccination rates
Chinese capital rolls out grading system as part of campaign to vaccinate 560m people by June

Helen Davidson in Taipei

08, Apr, 2021 @8:10 AM

Article image
EU approves Moderna jab amid tensions over slow rollout of vaccines
Move should ease frustrations over low supplies of Pfizer vaccine and EU’s longer authorisation process

Jon Henley Europe correspondent

06, Jan, 2021 @4:34 PM

Article image
Global immunisation: low-income countries rush to access Covid vaccine supply
Despite efforts to procure Covid vaccine, some nations will only vaccinate 20% of population

Sarah Boseley Health editor

15, Jan, 2021 @12:23 PM